DEANS_MEDICARE_LTD - Accounts


Company Registration No. SC649557 (Scotland)
DEANS MEDICARE LTD
UNAUDITED FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 30 NOVEMBER 2020
PAGES FOR FILING WITH REGISTRAR
DEANS MEDICARE LTD
CONTENTS
Page
Balance sheet
1 - 2
Notes to the financial statements
3 - 5
DEANS MEDICARE LTD
BALANCE SHEET
AS AT 30 NOVEMBER 2020
30 November 2020
- 1 -
2020
Notes
£
£
Fixed assets
Tangible assets
3
3,473
Investments
4
5,193,875
5,197,348
Current assets
Debtors
5
9,600
Cash at bank and in hand
27,928
37,528
Creditors: amounts falling due within one year
6
(2,120,768)
Net current liabilities
(2,083,240)
Total assets less current liabilities
3,114,108
Creditors: amounts falling due after more than one year
7
(2,572,492)
Net assets
541,616
Capital and reserves
Called up share capital
8
100
Profit and loss reserves
541,516
Total equity
541,616

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

For the financial period ended 30 November 2020 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the period in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

DEANS MEDICARE LTD
BALANCE SHEET (CONTINUED)
AS AT 30 NOVEMBER 2020
30 November 2020
- 2 -
The financial statements were approved by the board of directors and authorised for issue on 30 August 2021 and are signed on its behalf by:
Mr Arif Hanif
Mr John Connolly
Director
Director
Company Registration No. SC649557
DEANS MEDICARE LTD
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 30 NOVEMBER 2020
- 3 -
1
Accounting policies
Company information

Deans Medicare Ltd is a private company limited by shares incorporated in Scotland. The registered office is 1st Floor, 133 Finnieston Street, Glasgow, United Kingdom, G3 8HB.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention, modified to include the revaluation of freehold properties and to include investment properties and certain financial instruments at fair value. The principal accounting policies adopted are set out below.

1.2
Turnover

Turnover comprises revenue recognised by the company in respect of management charges provided during the year, exclusive of Value Added Tax.

1.3
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Plant and equipment
20% straight line
1.4
Fixed asset investments

Interests in subsidiaries, associates and jointly controlled entities are initially measured at cost and subsequently measured at cost less any accumulated impairment losses. The investments are assessed for impairment at each reporting date and any impairment losses or reversals of impairment losses are recognised immediately in profit or loss.

A subsidiary is an entity controlled by the company. Control is the power to govern the financial and operating policies of the entity so as to obtain benefits from its activities.

An associate is an entity, being neither a subsidiary nor a joint venture, in which the company holds a long-term interest and where the company has significant influence. The company considers that it has significant influence where it has the power to participate in the financial and operating decisions of the associate.

1.5
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

DEANS MEDICARE LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 30 NOVEMBER 2020
1
Accounting policies
(Continued)
- 4 -
1.6
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

1.7
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

2
Employees

The average monthly number of persons (including directors) employed by the company during the period was 2.

3
Tangible fixed assets
Plant and machinery etc
£
Cost
At 13 December 2019
-
0
Additions
4,341
At 30 November 2020
4,341
Depreciation and impairment
At 13 December 2019
-
0
Depreciation charged in the period
868
At 30 November 2020
868
Carrying amount
At 30 November 2020
3,473
4
Fixed asset investments
2020
£
Investments
5,193,875
DEANS MEDICARE LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 30 NOVEMBER 2020
4
Fixed asset investments
(Continued)
- 5 -
Movements in fixed asset investments
Shares in group undertakings
£
Cost or valuation
At 13 December 2019
-
Additions
5,193,875
At 30 November 2020
5,193,875
Carrying amount
At 30 November 2020
5,193,875
5
Debtors
2020
Amounts falling due within one year:
£
Trade debtors
9,600
6
Creditors: amounts falling due within one year
2020
£
Bank loans
213,754
Taxation and social security
6,256
Other creditors
1,900,758
2,120,768
7
Creditors: amounts falling due after more than one year
2020
£
Bank loans and overdrafts
2,572,492
8
Called up share capital
2020
£
Ordinary share capital
Issued and fully paid
100  of £1 each
100
2020-11-302019-12-13false30 August 2021CCH SoftwareCCH Accounts Production 2021.200No description of principal activityMr A HanifMr J ConnollySC6495572019-12-132020-11-30SC6495572020-11-30SC649557core:OtherPropertyPlantEquipment2020-11-30SC649557core:CurrentFinancialInstruments2020-11-30SC649557core:Non-currentFinancialInstruments2020-11-30SC649557core:ShareCapital2020-11-30SC649557core:RetainedEarningsAccumulatedLosses2020-11-30SC649557bus:Director12019-12-132020-11-30SC649557bus:Director22019-12-132020-11-30SC649557core:PlantMachinery2019-12-132020-11-30SC649557core:OtherPropertyPlantEquipment2019-12-12SC649557core:OtherPropertyPlantEquipment2019-12-132020-11-30SC649557bus:PrivateLimitedCompanyLtd2019-12-132020-11-30SC649557bus:SmallCompaniesRegimeForAccounts2019-12-132020-11-30SC649557bus:FRS1022019-12-132020-11-30SC649557bus:AuditExemptWithAccountantsReport2019-12-132020-11-30SC649557bus:FullAccounts2019-12-132020-11-30xbrli:purexbrli:sharesiso4217:GBP